Cognitive Remediation Method by Rhythmic, Vocal and Embodied Musical Learning for Stabilized Schizophrenic Patients
ARCoS
Pilot Study Evaluating the Feasibility and the Preliminary Effects of a Cognitive Remediation Method by Rhythmic, Vocal and Embodied Musical Learning for Stabilized Schizophrenic Patients.
1 other identifier
interventional
20
1 country
2
Brief Summary
ARCoS is a pilot study evaluating the feasibility and preliminary effects of a method of cognitive remediation by a Rhythmic, Vocal and Embodied Musical Learning for a population of stabilized schizophrenic patients. 20 stabilized schizophrenics patients will participate in the study for 9 months, i) 6 months of Musical learning (24 sessions over the 6 months) ; ii) and 3 months of follow-up post cognitive remediation. Assessments of attention deficits, inhibitory abilities, negative symptoms and anxiety, will carried out at baseline (V1, M0), third month (M3), sixth month (M6) after the start of the intervention and third months after the end of the intervention (M9). The primary endpoint will be the proportion of patients who have attended at least 80% of the musical training sessions over the 6 months (participation in at least 19/24 sessions).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable schizophrenia
Started Dec 2021
Shorter than P25 for not_applicable schizophrenia
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 27, 2021
CompletedFirst Posted
Study publicly available on registry
November 18, 2021
CompletedStudy Start
First participant enrolled
December 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 21, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
October 21, 2022
CompletedMarch 31, 2023
March 1, 2023
11 months
October 27, 2021
March 29, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
proportion of patients who have attended at least 80% of the musical training sessions over the 6 months
The primary outcomes will be the proportion of patients who have attended at least 80% of the musical training sessions over the 6 months (participation in at least 19/24 sessions).
6 months
Secondary Outcomes (10)
list of factors of no adherence to musical learning
6 months
Reduce of attention deficits at 6 month
6 months
Reduce of attention deficits at 9 month
9 months
Improving inhibitory abilities at 6 month
6 months
Improving inhibitory abilities at 9 month
9 months
- +5 more secondary outcomes
Study Arms (1)
musical training sessions
EXPERIMENTAL24 musical training sessions over the 6 months + 3 months of follow-up post cognitive remediation.
Interventions
The musical learning method "Diapason \& Metronome" is unprecedented. It was specially created by Florent Cholat. It aims an apprenticeship of a musical practice adapted to subjects with schizophrenia. The method does not require the handling of a musical instrument; it is based on the voice and the body. It is built on the three essential dimensions of music, which are rhythm, single sound and harmony. "Rhythm" concerns the division and management of time. The "single sound" allows work on the representation of a sound object as a singularity. "Harmony" allows you to work on the positioning of a sound in the globality of the chord to which it belongs and in the collective polyphony exercises.
Eligibility Criteria
You may qualify if:
- Established schizophrenia or with schizoaffective disorder as per Diagnostic and Statistical Manual (DSM 5)
- Clinically stable (with no full-time hospitalization within the last 6 months)
- Regular follow-up (followed in a day Hospital of Psychiatric)
- Patient must be on stable background antipsychotic treatment (with no modification within the last 6 month)
- \. Male or female patients who are 18-60 years of age 5. Signed and dated written consent 6. Patient having a health Insurance coverage
You may not qualify if:
- Patient with moderate to severe intellectual disabilities (clinical criteria)
- Addictive comorbidity (excluding tobacco and behavioral addictions)
- Previous neurologic pathology with cognitive impact
- Patient who are following a cognitive rehabilitation program
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
CH Marchant
Toulouse, France
CHU Toulouse
Toulouse, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
TUDI L GOZE, MD
University Hospital, Toulouse
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 27, 2021
First Posted
November 18, 2021
Study Start
December 1, 2021
Primary Completion
October 21, 2022
Study Completion
October 21, 2022
Last Updated
March 31, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will not share